Humanized antibodies against the betaamyloyd peptide

Details for Australian Patent Application No. 2008299516 (hide)

Owner Delenex Therapeutics AG University of Zurich

Inventors Nitsch, Roger; Auf Der Maur, Adrian; Ewert, Stefan; Cattepoel, Susann

Agent Davies Collison Cave

Pub. Number AU-A-2008299516

PCT Pub. Number WO2009/033309

Priority 61/083,698 25.07.08 US; 60/993,612 13.09.07 US

Filing date 15 September 2008

Wipo publication date 19 March 2009

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

G01N 33/53 (2006.01) Investigating or analysing materials by specific methods not covered by groups - Immunoassay

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/033309 Priority application(s): WO2009/033309

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008299523-Process for the production of medium and high purity silicon from metallurgical grade silicon

2008299501-Reminder device for eliciting behavioral response in a vehicle